THURSDAY, Sept. 25, 2025 -- Psilocybin-assisted therapy (PAT) shows long-term safety and efficacy for treating symptoms of major depressive disorder...

THURSDAY, Oct. 2, 2025 -- Soft drink consumption may contribute to major depressive disorder (MDD) through alterations in gut microbiota, according to...

TUESDAY, Sept. 30, 2025 -- Elinzanetant, a dual neurokinin-targeted therapy, is effective for treating menopause-associated moderate-to-severe...

A new study has found that psychotherapy can lead to observable changes in the physical structure of the brain for people with major depressive...

MONDAY, Sept. 22, 2025 -- Receiving remote behavioral urinary incontinence (UI) treatment through either a mobile health app or video visit improves...

THURSDAY, Sept. 25, 2025 -- Oral semaglutide (25 mg) is effective for weight loss in adults with overweight or obesity without diabetes, according to...

THURSDAY, Sept. 25, 2025 -- Oral semaglutide (25 mg) is effective for weight loss in adults with overweight or obesity without diabetes, according to...

THURSDAY, Sept. 25, 2025 -- Low adherence to the Mediterranean diet is associated with severe periodontal disease and greater systemic inflammation,...

THURSDAY, Sept. 25, 2025 -- Low adherence to the Mediterranean diet is associated with severe periodontal disease and greater systemic inflammation,...

THURSDAY, Sept. 25, 2025 -- Remote perioperative telemonitoring (RPM) improves postoperative functional recovery and symptoms among patients...